Home
Akums Drugs & Pharmaceuticals Ltd Board of Directors
Board of Directors at Akums Drugs & Pharmaceuticals Ltd
Company Sec. & Compli. Officer
Independent Director
Independent Director
Independent Director
Managing Director
Key Highlights
- SANDEEP JAIN continues to serve as the Managing Director in 2025, maintaining the same position as in the previous year.
- SANJEEV JAIN continues to serve as the Managing Director in 2025, maintaining the same position as in the previous year.
- Matangi Gowrishankar continues to serve as the Independent Director in 2025, maintaining the same position as in the previous year.
- Dharamvir Malik continues to serve as the Company Sec. & Compli. Officer in 2025, maintaining the same position as in the previous year.
- Kewal Kundanlal Handa continues to serve as the Independent Director in 2025, maintaining the same position as in the previous year.
Akums Drugs & Pharmaceuticals Ltd
NSE: AKUMS
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 17 Dec 2025 | 420.45 |
| 16 Dec 2025 | 420.1 |
| 15 Dec 2025 | 422.65 |
| 12 Dec 2025 | 423.3 |
| 11 Dec 2025 | 430.55 |
| 10 Dec 2025 | 425.9 |
| 09 Dec 2025 | 421.55 |
| 08 Dec 2025 | 419.75 |
| 05 Dec 2025 | 419.5 |
| 04 Dec 2025 | 420.3 |
Company Fundamentals for Akums Drugs & Pharmaceuticals Ltd
Market Cap
6,617 Cr
EPS
19.5
P/E Ratio (TTM)
21.5
P/B Ratio (TTM)
2.1
Day’s High
427.0
Day’s Low
417.8
DTE
0.0
ROE
10.1
52 Week High
678.8
52 Week Low
407.4
ROCE
9.0
Market Price of Akums Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Akums Drugs & Pharmaceuticals Ltd News Hub
Akums Drugs and Pharmaceuticals rises on debut
The scrip was listed at Rs 725, exhibiting a 6.77% premium to the issue price. So far, the stock has
Read more
06 Aug 24
Akums Drugs and Pharmaceuticals IPO ends with strong subscription
The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,36,79,134 bids for sha
Read more
02 Aug 24
Akums Drugs and Pharmaceuticals IPO subscribed 63.44 times
The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,18,57,204 bids for sha
Read more
01 Aug 24
Akums Drugs & Pharmaceuticals reports consolidated net profit of Rs 60.17 crore in the June 2024 quarter
Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 202
Read more
26 Aug 24
